Pharmacobiochemistry of arylalkyltriazenes and their application in cancer chemotherapy
- PMID: 3901047
- DOI: 10.1016/0163-7258(85)90074-9
Pharmacobiochemistry of arylalkyltriazenes and their application in cancer chemotherapy
Similar articles
-
Ames test of 1-(X-phenyl)-3,3-dialkyltriazenes. A quantitative structure-activity study.J Med Chem. 1979 May;22(5):473-6. doi: 10.1021/jm00191a003. J Med Chem. 1979. PMID: 379331
-
[DTIC and its derivatives: cytotoxic or antimetastatic drugs?].G Ital Chemioter. 1985 Jan-Apr;32(1):43-7. G Ital Chemioter. 1985. PMID: 3830793 Italian. No abstract available.
-
Metabolic activation of triazene cytostatics.Adv Exp Med Biol. 1981;136 Pt B:1285-96. Adv Exp Med Biol. 1981. PMID: 7344512 No abstract available.
-
Anticancer Triazenes: from Bioprecursors to Hybrid Molecules.Curr Pharm Des. 2019;25(14):1623-1642. doi: 10.2174/1381612825666190617155749. Curr Pharm Des. 2019. PMID: 31244412 Review.
-
QSAR in cancer chemotherapy.Farmaco Sci. 1979 Jan;34(1):89-104. Farmaco Sci. 1979. PMID: 399923 Review.
Cited by
-
4-amino-substituted benzenesulfonamides as inhibitors of human carbonic anhydrases.Molecules. 2014 Oct 28;19(11):17356-80. doi: 10.3390/molecules191117356. Molecules. 2014. PMID: 25353386 Free PMC article.
-
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma.J Neurooncol. 2000 Sep;49(3):255-61. doi: 10.1023/a:1006454427026. J Neurooncol. 2000. PMID: 11212905 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources